EndoC-H1 sublines were maintained in DMEM at 5 mM d-glucose supplemented with 2% BSA, 50 M -mercaptoethanol, 10 mM nicotinamide, 5.5 g ml 1 transferrin, 6.7 ng ml 1 sodium selenite, and 1% penicillin/streptomycin 40
10.1159/000177999 [DOI] [PubMed] [Google Scholar] Akagi M, Matsui N, Akae H, Hirashima N, Fukuishi N, Fukuyama Y, Akagi R (2015) Nonpeptide neurotrophic agents useful in the treatment of neurodegenerative diseases such as Alzheimers disease
Current Research and Clinical Trials Early Findings and Promising Results The exploration into GLP-1 receptor agonists (GLP-1 RAs) for depression is still in its early stages, but the initial findings are quite encouraging
Peptides and Recovery: A New Lens on Inflammation Beyond metabolism, peptides are also being studied in the realm of injury recovery and inflammation
This difference in how they work might lead to varied results for different people